Exercise in Patients Admitted With Recently Decompensated Heart Failure

Status Completed

Clinical Trial Summary

An aerobic physical exercise protocol will be applied to patients admitted in ward due to decompensated heart failure, in order to validate the efficacy and safety of physical exercise in this phase of clinical stabilization, through the said training protocol - ERIC program.

Clinical Trial Description

With the objective of validating the efficacy and safety of physical exercise as a therapeutic resource in patients admitted for decompensated heart failure; will be applied, by rehabilitation nurses, a protocol of physical exercise, with increasing levels of intensity. Patients who meet the inclusion criteria will be randomized through an online program (randomizer.org) and the ERIC protocol will be applied to the test group. The control group will be implemented the usual care of rehabilitation nursing. The ERIC protocol comprises 5 levels of intensity, as following shown: Stage 1 - respiratory and calisthenic exercises (5-10 minutes) Stage 2 - pedal for 5-10 minutes Stage 3 - aerobic training: walking on the corridor for 5-10 minutes Stage 4 - aerobic training: walking on the corridor for 10-15 minutes Stage 5 - aerobic training: walking on the corridor for 15 minutes + climbing stairs for 5 minutes All patients will be monitored and followed up by a rehabilitation nurse while they are doing the exercise. The investigator decides, depending on the patient's performance and clinical conditions, the form of progression in the program, but it is mandatory to follow the previously defined levels of intensity. Patients in the test group may start the program only on stage I or II according to clinical criteria. At admission of the patients (test group and control group) clinical and sociodemographic parameters are evaluated, as well as data related to Barthel's indices and London Chest of activities of daily living (LCADL). At the discharge date, the Barthel index and the LCADL scale will also be evaluated, as well as the 6-minute walking test. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03838003
Study type	Interventional
Source	Universidade do Porto
Contact
Status	Completed
Phase	N/A
Start date	September 1, 2017
Completion date	September 30, 2019

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05910437` - Optimizing Treatments for Heart Failure During Hospitalization
Terminated	`NCT00355017` - BNP Guided Care in Addition to Multidisciplinary Care	N/A
Active, not recruiting	`NCT03701880` - Early Use of Ivabradine in Heart Failure	N/A
Recruiting	`NCT03157219` - Manipal Heart Failure Registry (MHFR)	N/A
Recruiting	`NCT06114498` - Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction
Recruiting	`NCT02997462` - Monocyte Phenotypic Changes in Heart Failure
Completed	`NCT04493346` - Shear Wave Elastography
Recruiting	`NCT02666651` - Regional Tolvaptan Registry	Phase 4
Recruiting	`NCT02236247` - Control of Sinus Node Tachycardia as an Additional Therapy in Patients With Decompensated Heart Failure	Phase 1/Phase 2
Not yet recruiting	`NCT06273397` - Acetazolamide or Metolazone in Acute Heart Failure	N/A
Recruiting	`NCT06286423` - Colchicine in Acutely Decompensated HFREF	Phase 4
Completed	`NCT05927285` - Effect on Kidney Function Recovery Guiding Decongestion With VExUS in Patients With Cardiorenal Syndrome 1	N/A
Withdrawn	`NCT04572867` - Aquapheresis Efficacy in Outpatients With Decompensated Heart Failure	N/A
Completed	`NCT02157506` - A Dose Ranging Phase IIa Study of 6 Hour Intravenous Dosages of CXL-1427 in Patients Hospitalized With Heart Failure	Phase 2
Recruiting	`NCT03914222` - Comparing PA Compliance During and After Decompensation in HFP	N/A
Recruiting	`NCT03009552` - Speckle Tracking Echocardiography Adds Information in Decompensated Heart Failure	N/A
Completed	`NCT04019314` - Assessment of ProEnkephalin to Detect Acute Kidney Injury (AKI)	N/A
Recruiting	`NCT02649517` - Clinical and Morphological Characteristics of Chronic Inflammation in the Myocardium in Patients With Decompensated HF With Ischemic Systolic Dysfunction	N/A
Recruiting	`NCT03440970` - Mechanism and Effects of Manipulating Chloride Homeostasis in Stable Heart Failure	Early Phase 1
Recruiting	`NCT05090930` - Innovative Technologies for the Treatment of Pulmonary and Heart Failure	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Exercise in Patients Admitted With Recently Decompensated Heart Failure — ERIC

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms